TYRA BIOSCIENCES INC's ticker is and the CUSIP is 90240B106. A total of 60 filers reported holding TYRA BIOSCIENCES INC in Q2 2023. The put-call ratio across all filers is - and the average weighting 1.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $53,686,847 | -23.4% | 3,898,827 | -5.3% | 0.01% | -16.7% |
| Q2 2023 | $70,110,279 | -30.7% | 4,116,869 | -34.6% | 0.01% | +20.0% |
| Q1 2023 | $101,176,304 | +243.2% | 6,295,974 | +62.3% | 0.01% | +66.7% |
| Q4 2022 | $29,481,335 | -16.7% | 3,879,123 | -3.7% | 0.00% | -25.0% |
| Q3 2022 | $35,391,000 | +24.7% | 4,026,301 | +1.5% | 0.00% | +33.3% |
| Q2 2022 | $28,372,000 | -35.2% | 3,968,090 | -3.0% | 0.00% | 0.0% |
| Q1 2022 | $43,764,000 | -10.3% | 4,090,085 | +17.9% | 0.00% | -25.0% |
| Q4 2021 | $48,806,000 | +45.4% | 3,468,831 | +81.7% | 0.00% | +33.3% |
| Q3 2021 | $33,573,000 | – | 1,908,659 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Canaan Partners XI LLC | 4,409,991 | $60,725,576 | 53.26% |
| Nextech Invest Ltd. | 2,518,582 | $34,680,874 | 10.51% |
| Boxer Capital, LLC | 6,448,359 | $88,793,903 | 4.73% |
| TCG Crossover Management, LLC | 1,989,103 | $27,389,948 | 4.03% |
| Fairmount Funds Management LLC | 1,393,329 | $19,186,140 | 2.31% |
| RA Capital Management | 7,236,454 | $99,645,972 | 1.96% |
| 5AM Venture Management, LLC | 411,450 | $5,665,667 | 1.63% |
| BVF INC/IL | 2,739,595 | $37,724,223 | 1.02% |
| Frazier Life Sciences Management, L.P. | 1,028,013 | $14,155,739 | 0.94% |
| Auour Investments LLC | 85,020 | $1,198,782 | 0.51% |